Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

RTA 408 cream protects mice from radiation skin damage.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.